Lizzie Shephard

@lizzieshephard.bsky.social

Developmental neuroscientist / psychologist interested in the perinatal period & neurodiversity affirming supports for young kids and their caregivers. https://sites.usp.br/ninalab/

Excited to be editing a Developmental Science special issue on Culture, Context, and Brain Development with Heather Bortfeld, Laura Katus, and Bruce Rawlings. Seeking papers from diverse contexts using novel approaches! onlinelibrary.wiley.com/page/journal... Please share!

Developmental Science Call for Papers Culture, context, and brain development

Developmental Science is an international journal publishing contemporary scientific developmental psychology and developmental cognitive neuroscience research.

onlinelibrary.wiley.com

📰 New #openaccess protocol paper "This study is one small, but important, step towards autism-specific, relevant, and accessible supports that combine professional and lived experience to improve outcomes for autistic people and their families."

Protocol for a feasibility and acceptability trial of Bloom, a co-produced and co-facilitated parent group to enhance the quality of life and well-being of young autistic children - Pilot and Feasibility Studies

Background The autistic and autism communities have identified improving the quality of life and well-being of autistic people as a key priority. Despite this, to date, there are no evidence-based supports for autistic children which specifically focus on improvements in these areas. This project seeks to address this gap by evaluating the acceptability and feasibility of Bloom, an 8-week co-produced and co-facilitated parent group that aims to enhance the quality of life and well-being of young autistic children. Methods This is a feasibility and acceptability study of a parent group, Bloom, which has been co-designed and co-produced between researchers and representatives from community organisations. The study aims to recruit 80 parents of autistic children aged 3–8 years through community organisations and social media networks. Once informed consent is provided, participants will be asked to complete baseline assessments (questionnaires and semi-structured interviews). These include measures of demographic as well as child, family, and parent well-being. Participants will be invited to attend the Bloom group for eight consecutive weeks during school term times. Groups will either be online or face to face, depending on parent preference and availability. Each group will be co-facilitated between an autistic person and an allied health professional. The assessments conducted at baseline (T1) will be repeated after completion of the group (T2) and at follow-up, 3 months after group completion (T3). At T2 and T3, participants will also be asked about their experiences of both the group and of their participation in the study. Discussion This feasibility and acceptability trial will provide essential data that, if positive, will inform the design of a fully powered randomised controlled trial (RCT). This includes the acceptability and feasibility of recruitment, study processes, the Bloom parent group, and baseline/outcome measures, including adherence to processes and the group. Additional data will be collected on retention from baseline to follow-up; effect sizes will be calculated for each outcome measure, both of which will inform the sample size of a future RCT. Findings of this study will be disseminated through written and/or audiovisual lay summaries to all participants and partner community organisations, as well as through peer-reviewed manuscripts and conference presentations. Conclusions This study is one small, but important, step towards autism-specific, relevant, and accessible supports that combine professional and lived experience to improve outcomes for autistic people and their families. Trial registration Ethical clearance was provided by Griffith University Human Research Ethics Committee (HREC 2023/934). The Universal Trial Number is U1111-1305-0305, and the study has been registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12624000350527.

doi.org

Should ethics be a university ranking indicator? Global rankings (such as QS and THES) influence university behaviour far more than many institutions would like to admit. Universities change strategy, allocate resources, restructure priorities and set targets based on ranking methodologies. 🧵

Bild

1. London Underground station flooding has reportedly been reduced by around 90% thanks to a group of engineers: beavers. After conservationists reintroduced a family of beavers into a nearby city park, the animals built dams and restored wetlands that now absorb and slow floodwater naturally.

Our recap of #INSAR2026 is (finally) up! While there was much to celebrate in terms of autistic presence and impact, there was still a lot of weird old guard INSAR focus on autism as a problem to solve, rather than of autistic people as participants or fully human: tinyurl.com/INSAR2026TPGA #autism

INSAR 2026: The State of Autism Research, Prague Version — THINKING PERSON'S GUIDE TO AUTISM

We've been covering INSAR for 15 years. It is fascinating how the autism research landscape both has and has not evolved during that stretch.

tinyurl.com

2 new copyrighted measures dictating what autistics should do in research, and how?--a lot of autistic contributions (e.g. mine) get graded poorly, disparaged as non-meaningful, non-genuine, etc journals.sagepub.com/doi/10.1177/... authors gave "paid guest lectures" on this & declare no COIs?

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

Very happy to share that Priscilla Godoy and I were awarded a new grant to conduct our implementation+effectiveness study of PACT in the Brazil public health system, which we are co-producing with Brazilian autistic adults and parents. We even have services in the middle of the Amazon...!!

Delighted to start the week with the first paper from my lab being accepted for publication. We report preliminary data on the feasibility of the preemptive iBASI therapy to support the early development of infants with family history of autism and ADHD in Brazil.